Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis (Q28254097)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis
scientific article

    Statements

    title
    Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis (English)
    0 references
    main subject
    sepsis
    0 references
    patient
    0 references
    toll-like receptor
    0 references
    author
    Steven Opal
    series ordinal
    9
    object named as
    Steven M Opal
    0 references
    author name string
    Mark Tidswell
    series ordinal
    1
    0 references
    William Tillis
    series ordinal
    2
    0 references
    Steven P Larosa
    series ordinal
    3
    0 references
    Melvyn Lynn
    series ordinal
    4
    0 references
    Alec E Wittek
    series ordinal
    5
    0 references
    Richard Kao
    series ordinal
    6
    0 references
    Janice Wheeler
    series ordinal
    7
    0 references
    Jagadish Gogate
    series ordinal
    8
    0 references
    publication date
    January 2010
    0 references
    volume
    38
    0 references
    issue
    1
    0 references
    page(s)
    72-83
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254097&oldid=1899000172"